Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer

J. D. Minna, J. Schutte, J. Viallet, F. Thomas, F. J. Kaye, T. Takahashi, M. Nau, J. Whang-Peng, M. Birrer, A. F. Gazdar

Research output: Contribution to journalArticle

Abstract

Natural killer cells are characterized by the lack of CD3/TCR molecules and by the expression of CD16 and CD56(NKH1 or Leu 19) surface antigens. In addition to their ability to lyse certain tumor target cells, they release lymphokines including tumor necrosis factor and interferon gamma. Another unexpected functional capability of at least some NK cells is the ability to specifically recognize and lyse certain normal allogeneic cells (PHA-induced blasts). MAbs directed to CD2 or to CD 16 surface molecules induces triggering of NK cells leading to target cell (p815) lysis in a redirected killing assay. Importantly, different from unduction of T cell activation, single anti-CD2 MAbs were sufficient to trigger NK cell function. Another MAb (GL183) inducing NK cell triggering recognized a novel surface molecules expressed on 20-50% of resting or cultured NK cells. Clones GL183+ cells displayed a variable degree of cytolytic activity against a number of human target cells of different histotype; moreover, this activity was strongly enhanced by the addition of GL183 MAb. On the other hand, GL183 MAb inhibited lysis of murine lines (including P815). Thus on P815 target cells GL183 MAb has an effect antithetical to that of other stimuli including PHA, anti CD2 or anti-CD16 MAbs. GL183 MAb, added simultaneously to one or another of the stimuli above, strongly inhibited the target cell lysis induced by these stimuli. Thus, GL183 may represent an important molecule in the process of activation/regulation of phenotypically-defined NK cell subsets.

Original languageEnglish
Pages (from-to)32-34
Number of pages3
JournalInternational Journal of Cancer
Issue numberSUPPL. 4
Publication statusPublished - Jan 1 1989
Externally publishedYes

Fingerprint

Tumor Suppressor Genes
Natural Killer Cells
Lung Neoplasms
Transcription Factors
CD56 Antigens
Lymphokines
Surface Antigens
Interferon-gamma
Cultured Cells
Clone Cells
Tumor Necrosis Factor-alpha
T-Lymphocytes
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Minna, J. D., Schutte, J., Viallet, J., Thomas, F., Kaye, F. J., Takahashi, T., ... Gazdar, A. F. (1989). Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer. International Journal of Cancer, (SUPPL. 4), 32-34.

Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer. / Minna, J. D.; Schutte, J.; Viallet, J.; Thomas, F.; Kaye, F. J.; Takahashi, T.; Nau, M.; Whang-Peng, J.; Birrer, M.; Gazdar, A. F.

In: International Journal of Cancer, No. SUPPL. 4, 01.01.1989, p. 32-34.

Research output: Contribution to journalArticle

Minna, JD, Schutte, J, Viallet, J, Thomas, F, Kaye, FJ, Takahashi, T, Nau, M, Whang-Peng, J, Birrer, M & Gazdar, AF 1989, 'Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer', International Journal of Cancer, no. SUPPL. 4, pp. 32-34.
Minna JD, Schutte J, Viallet J, Thomas F, Kaye FJ, Takahashi T et al. Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer. International Journal of Cancer. 1989 Jan 1;(SUPPL. 4):32-34.
Minna, J. D. ; Schutte, J. ; Viallet, J. ; Thomas, F. ; Kaye, F. J. ; Takahashi, T. ; Nau, M. ; Whang-Peng, J. ; Birrer, M. ; Gazdar, A. F. / Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer. In: International Journal of Cancer. 1989 ; No. SUPPL. 4. pp. 32-34.
@article{ac3fb652a82646e09765ddbd04e4f54b,
title = "Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer",
abstract = "Natural killer cells are characterized by the lack of CD3/TCR molecules and by the expression of CD16 and CD56(NKH1 or Leu 19) surface antigens. In addition to their ability to lyse certain tumor target cells, they release lymphokines including tumor necrosis factor and interferon gamma. Another unexpected functional capability of at least some NK cells is the ability to specifically recognize and lyse certain normal allogeneic cells (PHA-induced blasts). MAbs directed to CD2 or to CD 16 surface molecules induces triggering of NK cells leading to target cell (p815) lysis in a redirected killing assay. Importantly, different from unduction of T cell activation, single anti-CD2 MAbs were sufficient to trigger NK cell function. Another MAb (GL183) inducing NK cell triggering recognized a novel surface molecules expressed on 20-50{\%} of resting or cultured NK cells. Clones GL183+ cells displayed a variable degree of cytolytic activity against a number of human target cells of different histotype; moreover, this activity was strongly enhanced by the addition of GL183 MAb. On the other hand, GL183 MAb inhibited lysis of murine lines (including P815). Thus on P815 target cells GL183 MAb has an effect antithetical to that of other stimuli including PHA, anti CD2 or anti-CD16 MAbs. GL183 MAb, added simultaneously to one or another of the stimuli above, strongly inhibited the target cell lysis induced by these stimuli. Thus, GL183 may represent an important molecule in the process of activation/regulation of phenotypically-defined NK cell subsets.",
author = "Minna, {J. D.} and J. Schutte and J. Viallet and F. Thomas and Kaye, {F. J.} and T. Takahashi and M. Nau and J. Whang-Peng and M. Birrer and Gazdar, {A. F.}",
year = "1989",
month = "1",
day = "1",
language = "English",
pages = "32--34",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "SUPPL. 4",

}

TY - JOUR

T1 - Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer

AU - Minna, J. D.

AU - Schutte, J.

AU - Viallet, J.

AU - Thomas, F.

AU - Kaye, F. J.

AU - Takahashi, T.

AU - Nau, M.

AU - Whang-Peng, J.

AU - Birrer, M.

AU - Gazdar, A. F.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Natural killer cells are characterized by the lack of CD3/TCR molecules and by the expression of CD16 and CD56(NKH1 or Leu 19) surface antigens. In addition to their ability to lyse certain tumor target cells, they release lymphokines including tumor necrosis factor and interferon gamma. Another unexpected functional capability of at least some NK cells is the ability to specifically recognize and lyse certain normal allogeneic cells (PHA-induced blasts). MAbs directed to CD2 or to CD 16 surface molecules induces triggering of NK cells leading to target cell (p815) lysis in a redirected killing assay. Importantly, different from unduction of T cell activation, single anti-CD2 MAbs were sufficient to trigger NK cell function. Another MAb (GL183) inducing NK cell triggering recognized a novel surface molecules expressed on 20-50% of resting or cultured NK cells. Clones GL183+ cells displayed a variable degree of cytolytic activity against a number of human target cells of different histotype; moreover, this activity was strongly enhanced by the addition of GL183 MAb. On the other hand, GL183 MAb inhibited lysis of murine lines (including P815). Thus on P815 target cells GL183 MAb has an effect antithetical to that of other stimuli including PHA, anti CD2 or anti-CD16 MAbs. GL183 MAb, added simultaneously to one or another of the stimuli above, strongly inhibited the target cell lysis induced by these stimuli. Thus, GL183 may represent an important molecule in the process of activation/regulation of phenotypically-defined NK cell subsets.

AB - Natural killer cells are characterized by the lack of CD3/TCR molecules and by the expression of CD16 and CD56(NKH1 or Leu 19) surface antigens. In addition to their ability to lyse certain tumor target cells, they release lymphokines including tumor necrosis factor and interferon gamma. Another unexpected functional capability of at least some NK cells is the ability to specifically recognize and lyse certain normal allogeneic cells (PHA-induced blasts). MAbs directed to CD2 or to CD 16 surface molecules induces triggering of NK cells leading to target cell (p815) lysis in a redirected killing assay. Importantly, different from unduction of T cell activation, single anti-CD2 MAbs were sufficient to trigger NK cell function. Another MAb (GL183) inducing NK cell triggering recognized a novel surface molecules expressed on 20-50% of resting or cultured NK cells. Clones GL183+ cells displayed a variable degree of cytolytic activity against a number of human target cells of different histotype; moreover, this activity was strongly enhanced by the addition of GL183 MAb. On the other hand, GL183 MAb inhibited lysis of murine lines (including P815). Thus on P815 target cells GL183 MAb has an effect antithetical to that of other stimuli including PHA, anti CD2 or anti-CD16 MAbs. GL183 MAb, added simultaneously to one or another of the stimuli above, strongly inhibited the target cell lysis induced by these stimuli. Thus, GL183 may represent an important molecule in the process of activation/regulation of phenotypically-defined NK cell subsets.

UR - http://www.scopus.com/inward/record.url?scp=0024351395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024351395&partnerID=8YFLogxK

M3 - Article

C2 - 2530182

SP - 32

EP - 34

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - SUPPL. 4

ER -